more attention focused on urinary incontinence

You'll see more attention focused on urinary incontinence.

This is a big problem. More than 15 million people suffer from bladder problems...only about 10% seek help.

This attention is partly fueled by ads for two new drugs...Ditropan XL (oxybutynin) and Detrol (tolterodine). These drugs inhibit bladder contractions and delay the desire to void.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote